Abstract
Scleroderma heart disease is a major risk of death in systemic sclerosis (SSc). Mechanisms underlying myocardial damage are still unclear. We performed an extensive study of SSc patients with recent-onset symptoms for heart disease and examined the efficacy of immunosuppressive therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 526-535 |
| Number of pages | 10 |
| Journal | Seminars in Arthritis and Rheumatism |
| Volume | 43 |
| DOIs | |
| Publication status | Published - 2013 |
Keywords
- ANCA
- Heart disease
- Myocarditis
- Parvovirus B19
- Systemic sclerosis
- Treatment
Fingerprint
Dive into the research topics of 'Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver